| BURU 0.3705 31.80% | CTNT 0.0331 -17.25% | TZA 5.09 0.99% | SOXS 15.7 -6.55% | NOK 10.32 4.67% | PAPL 0.87 44.90% | TSLL 12.02 -7.04% | INTC 66.78 2.31% | QS 7.41 1.37% | BITO 10.68 -1.29% | NVDA 199.64 -1.41% | BYND 0.9501 -13.63% | SOXL 112.77 6.75% | TSLA 373.72 -3.56% | TQQQ 59.22 -1.64% | SPDN 9.15 0.44% | BMNG 1.46 -10.98% | AUUD 5.06 30.75% | AIXI 1.08 20.70% | AAL 11.78 2.43% | MEHA 0.1035 -19.77% | NVD 5.72 2.88% | SQQQ 55.66 1.70% | PLUG 3.18 -0.31% | MWYN 0.7 23.02% | SMR 12.715 -6.30% | KEEL 3.24 6.58% | PLTR 141.57 -7.24% | IREN 52.02 7.50% | CGC 1.22 -11.59% | NVTS 18.51 0.22% | MSOS 4.22 -17.42% | SPY 708.45 -0.39% | CPIX 3.9 27.87% | ONDS 10.54 -4.70% | APLD 36.35 12.09% | SOFI 18.32 -3.88% | CMCSA 31.64 7.73% | SMCI 26.75 -8.33% | POET 11.72 -8.22% | SCO 7.17 -4.91% | HIMS 28.15 -2.95% | XLF 51.8 -0.79% | SNAP 5.57 -4.62% | MARA 11.8 -0.34% | TLRY 6.94 -11.82% | AMD 305.33 0.62% | GRAB 3.96 -2.46% | OPEN 5.22 -3.87% | KWEB 28.43 -2.74%

MetLife Inc. (NYSE:MET) Quarterly Earnings Preview

MetLife Inc. (NYSE:MET) is set to release its quarterly earnings on November 5, 2025, after the market closes. Analysts have estimated an earnings per share (EPS) of $2.31, with revenue projected at $18.64 billion. MetLife is a leading global provider of insurance, annuities, and employee benefit programs, competing with companies like Prudential Financial and Aflac.

Analysts are optimistic about MetLife's performance, with the Zacks Consensus Estimate predicting an EPS of $2.33, a 20.7% increase from the previous year. This growth is driven by higher premiums, increased group benefits revenues, and strong international operations. Revenue is expected to reach $18.8 billion, reflecting a 7% year-over-year growth.

Despite these positive projections, MetLife faces challenges such as rising costs and weaker results in its Retirement and Income Solutions segment. These factors may temper profit gains. However, the earnings estimate has improved over the past month, indicating positive sentiment among analysts.

MetLife's financial metrics provide insight into its valuation and performance. The company has a price-to-earnings (P/E) ratio of approximately 12.43, showing the price investors are willing to pay for each dollar of earnings. The price-to-sales ratio is about 0.72, suggesting investors pay 72 cents for every dollar of sales.

The enterprise value to sales ratio is around 0.69, reflecting MetLife's valuation compared to its sales. The enterprise value to operating cash flow ratio is approximately 3.21, indicating how well the company can cover its enterprise value with its operating cash flow. The earnings yield is about 8.04%, providing insight into the return on investment for shareholders.

Published on: November 5, 2025